Company Overview and News
Sri Lanka has secured a US $ 50 million loan from the Asian Development Bank (ADB) for rooftop solar power generation project under the much hyped ‘Soorya bala sangramaya’ or battle for solar power programme.
FISI ATB FIISO FIISP
Sept 19, 2018 (LBO) – The Enterprise Sri Lanka projects which was launched by the Ministry of Finance has received Rs 8 billion ( USD 50 Million) from the Asian Development Bank for the rooftop solar power generation project.
SIX FOREIGN companies have so far “expressed interest” in partnering with Philippine National Oil Co. (PNOC) in the state-led firm’s plan to put up a liquefied natural gas (LNG) facility under a yet to be issued terms via a solicited scheme, its top official said.
The Asian Development Bank said on Tuesday it is expanding its presence in the Pacific islands, at a time of competition for influence there, opening seven new country offices and expecting its loans and grants in the region to top US$4 billion by 2020.
SYDNEY (Reuters) - The Asian Development Bank said on Tuesday it is expanding its presence in the Pacific islands, at a time of competition for influence there, opening seven new country offices and expecting its loans and grants in the region to top $4 billion by 2020.
Murugappa Group's financial services arm Cholamandalam Investment and Finance Company has secured over Rs 1,000 crore funding from Asian Development Bank by issuing bonds to the multi-lateral funding agency.
Sept 12, 2018 (LBO) – Sri Lanka’s cabinet nod has been received to obtain 50 million US dollars worth ADB loan to help fund rooftop solar power generation systems in Sri Lanka.
The Chinese government's top diplomat defended Beijing's Belt and Road infrastructure initiative during a visit to Pakistan on Saturday, rejecting criticism the project has saddled Pakistan with expensive debt.
THE National Power Corp. (Napocor) expects funding for the rehabilitation of the Agus-Pulangi hydroelectric power complex in Mindanao to come from multilateral lending agencies as well as China, its top official said.
The Asian Institute of Management (AIM) is currently developing projects in partnership with the government to further develop digital technology and data science in the country.
Not for distribution to United States newswire services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States.
STATE-LED PHILIPPINE National Oil Co. (PNOC) is seeking partners to build an integrated liquefied natural gas (LNG) hub under new terms that defines the project under a “solicited” scheme, after the government agency failed to attract acceptable proponents.
PNX ITOCY PNX3B PNXP PNX3A KEP ITOCF ATB
Asian Development Bank (ADB) today said it has approved $346 million loan to finance road improvement across a dozen districts in Karnataka. ADB and the Government of India today signed a $346 million loan agreement to finance improvement of over 400 kilometers of state highways that will enhance connectivity and access to economic centres across 12 districts in Karnataka, ADB said in statement.
The Philippine National Oil Co. (PNOC) is seeking partners to build an integrated liquefied natural gas (LNG) hub under new terms that defines it as a “solicited” project after the government agency failed to attract acceptable proponents.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to ASX:ATB / ASIAN DEVELOPMENT BANK on message board site Silicon Investor.